EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H28N2O4.HCl |
| Net Charge | 0 |
| Average Mass | 372.893 |
| Monoisotopic Mass | 372.18159 |
| SMILES | CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1.[H]Cl |
| InChI | InChI=1S/C18H28N2O4.ClH/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3;/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23);1H |
| InChIKey | KTUFKADDDORSSI-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | sympathomimetic agent A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| Applications: | sympathomimetic agent A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| acebutolol hydrochloride (CHEBI:2380) has part acebutolol(1+) (CHEBI:62101) |
| acebutolol hydrochloride (CHEBI:2380) has role anti-arrhythmia drug (CHEBI:38070) |
| acebutolol hydrochloride (CHEBI:2380) has role antihypertensive agent (CHEBI:35674) |
| acebutolol hydrochloride (CHEBI:2380) has role sympathomimetic agent (CHEBI:35524) |
| acebutolol hydrochloride (CHEBI:2380) has role β-adrenergic antagonist (CHEBI:35530) |
| acebutolol hydrochloride (CHEBI:2380) is a hydrochloride (CHEBI:36807) |
| IUPAC Name |
|---|
| N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide hydrochloride |
| Synonyms | Source |
|---|---|
| Acebutolol hydrochloride | KEGG COMPOUND |
| 3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide hydrochloride | ChemIDplus |
| dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride | ChemIDplus |
| (±)-3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide monohydrochloride | ChemIDplus |
| Brand Names | Source |
|---|---|
| Sectral | ChemIDplus |
| Prent | ChemIDplus |
| Neptal | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| Beilstein:6080568 | Beilstein |
| Gmelin:2181029 | Gmelin |
| CAS:34381-68-5 | KEGG COMPOUND |
| CAS:34381-68-5 | ChemIDplus |